Kidney Qi Deficiency Syndrome
Conditions
Interventions
Treatment Group :Formulation I Group and Formulation II Group
Control Group:Therapeutically Inactive Placebo
Sponsors
Beijing University of Chinese Medicine Dongzhimen Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Gender unrestricted, meeting the diagnostic criteria for Kidney Qi Deficiency (excluding other types of kidney deficiency); 2. Aged between 18 and 70 years inclusive; 3. Voluntarily participate in this research study, sign the informed consent form, and agree to comply with the treatment.
Exclusion criteria
Exclusion criteria: ,: **Exclusion Criteria:** 1. Presence of concomitant severe cardiovascular, cerebrovascular, digestive, immune, or endocrine system diseases. 2. Presence of concomitant acute or infectious diseases. 3. Individuals with psychiatric disorders that preclude cooperation with the study. 4. Women who are pregnant, lactating, or planning pregnancy. 5. Patients participating in other clinical trials or currently taking health products with similar effects or those known to affect kidney function. 6. Individuals with chronic alcoholism or substance abuse. 7. Individuals with impairments in swallowing or drinking. 8. Individuals whose lifestyle, work, or transportation circumstances hinder their ability to attend follow-up visits. 9. Individuals with known allergies to any component of the investigational product.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic Scale for Kidney Qi Deficiency Syndrome; | — |
Secondary
| Measure | Time frame |
|---|---|
| Diagnostic Scale for Male Reproductive Function;Diagnostic Scale for Female Reproductive Function; | — |
Countries
China
Contacts
Public ContactYi Shi
Beijing University of Chinese Medicine Dongzhimen Hospital
Outcome results
None listed